Co-Authors
This is a "connection" page, showing publications co-authored by Jamie Hirsch and Thomas McGinn.
Connection Strength
0.406
-
External validation of the IMPROVE-DD risk assessment model for venous thromboembolism among inpatients with COVID-19. J Thromb Thrombolysis. 2021 Nov; 52(4):1032-1035.
Score: 0.059
-
In-Hospital 30-Day Survival Among Young Adults With Coronavirus Disease 2019: A Cohort Study. Open Forum Infect Dis. 2021 Jun; 8(6):ofab233.
Score: 0.059
-
Incidence of Venous Thromboembolism and Mortality in Patients with Initial Presentation of COVID-19. J Thromb Thrombolysis. 2021 May; 51(4):897-901.
Score: 0.058
-
Validation of the IMPROVE-DD risk assessment model for venous thromboembolism among hospitalized patients with COVID-19. Res Pract Thromb Haemost. 2021 Feb; 5(2):296-300.
Score: 0.058
-
A Machine Learning Prediction Model of Respiratory Failure Within 48 Hours of Patient Admission for COVID-19: Model Development and Validation. J Med Internet Res. 2021 02 10; 23(2):e24246.
Score: 0.058
-
Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients. Thromb Haemost. 2021 Aug; 121(8):1043-1053.
Score: 0.058
-
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020 05 26; 323(20):2052-2059.
Score: 0.055